rdf:type |
|
lifeskim:mentions |
umls-concept:C0020564,
umls-concept:C0149721,
umls-concept:C0174494,
umls-concept:C0205263,
umls-concept:C0225828,
umls-concept:C0521942,
umls-concept:C0684321,
umls-concept:C0857121,
umls-concept:C1515655,
umls-concept:C1533691,
umls-concept:C2755994
|
pubmed:issue |
5
|
pubmed:dateCreated |
1994-6-14
|
pubmed:abstractText |
Previous studies have demonstrated that angiotensin II (Ang II) acts as a growth-promoting factor directly on cardiac myocytes and that angiotensin-converting enzyme inhibitor induces regression of hypertrophied hearts both in experimental animals and in humans. These results suggest that the renin-angiotensin system (RAS) is involved in the formation of left ventricular hypertrophy (LVH). To elucidate the role of RAS in the progression of cardiac hypertrophy, we evaluated the effect of an Ang II receptor antagonist on LVH in spontaneously hypertensive rats (SHRs) and investigated the molecular mechanisms by which antagonizing Ang II receptors reduces cell hypertrophy of myocytes using the in vitro model of mechanical stretch.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
2204-11
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8181146-Angiotensin II,
pubmed-meshheading:8181146-Angiotensin Receptor Antagonists,
pubmed-meshheading:8181146-Animals,
pubmed-meshheading:8181146-Benzimidazoles,
pubmed-meshheading:8181146-Biphenyl Compounds,
pubmed-meshheading:8181146-Hydralazine,
pubmed-meshheading:8181146-Hypertension,
pubmed-meshheading:8181146-Hypertrophy, Left Ventricular,
pubmed-meshheading:8181146-Male,
pubmed-meshheading:8181146-Myocardium,
pubmed-meshheading:8181146-Rats,
pubmed-meshheading:8181146-Rats, Inbred SHR,
pubmed-meshheading:8181146-Rats, Inbred WKY,
pubmed-meshheading:8181146-Renin-Angiotensin System,
pubmed-meshheading:8181146-Signal Transduction,
pubmed-meshheading:8181146-Tetrazoles
|
pubmed:year |
1994
|
pubmed:articleTitle |
Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
|
pubmed:affiliation |
Department of Medicine III, Tokyo University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|